HealthcareManufacturingBiotech & Life SciencesConsumerFintechHardware & SemiconductorsLogistics & Supply ChainEnterprise Software
C&D Emerging Industry Equity Investment is a professional equity asset management institution under C&D Group (a Fortune Global 500 state-owned enterprise), based in Xiamen, China. Founded in 2014, it focuses on venture and growth-stage investments in healthcare, advanced manufacturing, and TMT, while also acting as a fund-of-funds LP.
They made 2 investments in the last 12 months. Their most common stage is series-a (40% of deals). Average disclosed round size is $48.3M (across 3 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
CX
Cai Xiaofan
Head of Xiamen C&D Emerging Industry Equity Investment
XC
Xiaobo Cynthia Wang
Healthcare & Biotech VC/PE
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| VVivacta Biotechnology | Series A | $50M | Apr 2026 |
 Vidu | Series A | — | Feb 2026 |
| KKind Pharmaceuticals | Series C | — | Jan 2025 |
 Oricell Therapeutics | Series B | $45M | Feb 2023 |
| YYellow Swan | Series C | — | Jan 2022 |
| SShengSheng | Series C | — | Jan 2021 |
| SShengSheng | Series B | — | Jan 2020 |
| SShengSheng | Series A | — | Jan 2018 |
| SShengSheng | Seed | — | Jan 2017 |
| VVivacta | Series A | $50M | — |
Top Co-Investors
Apricot Capital3 shared
Qiming Venture Partners USA2 shared
Nexus Venture Partners2 shared
Hankang Capital2 shared
Loyal Valley Capital2 shared
Decheng Capital2 shared
OrbiMed2 shared
Beijing Artificial Intelligence Industry Investment Fund1 shared
LinkX Capital1 shared
Beijing Zhongguancun Science City Innovation Development Co., Ltd.1 shared
RTW Investments, LP1 shared
Qatar Investment Authority1 shared
Viking Global1 shared
Idinvest1 shared
Spark Capital1 shared
Industry Ventures1 shared
Hillhouse Investment1 shared
Legend Capital1 shared
Northern Light Venture Capital1 shared
Gaorong Capital1 shared
Last updated: 14 September 2026